Quintiles to open bio-medicine lab in Shanghai

By Cai Wenjun | June 18, 2012, Monday |

Online Edition

THE state-owned Shanghai Clinical Research Center today signed an agreement with the US-based Quintiles, the world's largest bio-pharmaceutical services provider, to set up a joint venture lab to boost new drug development in China.

Chronic diseases common among elderly people will be a focus of research at the new laboratory in Shanghai, said Qunintiles, which will invest US$14 million in its China headquarters and local lab in the Fenglin Life Science Park in Xuhui District and hire about 450 employees in the next five years.

In addition to developing new drugs, the lab will also tap the potentials of traditional Chinese medicine in pharmaceutical research and development.

Health and Science

About Us
|
Terms of Use
|
RSS
|
Privacy Policy
|
Contact Us
|
Shanghai Call Center: 962288
|
Tip-off hotline: 52920043

沪ICP证：沪ICP备05050403
|
网络视听许可证：0909346
|
广播电视节目制作许可证：沪字第354号
|
增值电信业务经营许可证：沪B2-20120012

Quintiles to open bio-medicine lab in Shanghai

Email this to your friend